Utah's Amedica eyes $35 million IPO

Devicemaker Amedica is planning to go public with its sights on a $35 million IPO, offering 3.2 million shares at around $10 to $12 a piece. The Salt Lake City-based spinal implant specialist would operate under the Nasdaq symbol "AMDA." Item

Suggested Articles

The Rady Children’s Institute for Genomic Medicine tapped Deloitte to help develop a network of flying drones to deliver genetic testing specimens.

The FDA approved a new, tiny pacemaker from Medtronic that does not require the wiring of separate electrodes between the implant and the heart.

The respiratory care company Vyaire Medical has brought on a new CEO, Gaurav Agarwal, following a year of new product launches.